FGFR1 and cancer: In conclusion, the presented results suggest that 5,7-dimethyl-oxazolo[5,4-d]pyrimidine-5,7(4H,6H)-dione derivatives may serve as potential agents for the treatment of FGFR1-mediated cancers.